JVJoseph P. Vogel

Joseph P. Vogel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Joseph P. Vogel has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Deubiquitination of phosphoribosyl-ubiquitin conjugates by PDE domain-containing Legionella effectors

    by Min Wan, Alan Sulpizio, Anil Akturk, Wendy H.J. Beck, Michael Lanz, Vitor M. Faça, Marcus B. Smolka, Joseph P. Vogel, Yuxin Mao

    Summary: Posttranslational protein modification by ubiquitin (Ub) is a central eukaryotic mechanism that regulates a plethora of physiological processes. Recent studies unveiled an unconventional type of ubiquitination mediated by the SidE family of Legionella pneumophila effectors, such as SdeA, that catalyzes the conjugation of Ub to a serine residue of target proteins via a phosphoribosyl linker (hence named PR-ubiquitination). Comparable to the deubiquitinases (DUBs) in the canonical ubiquitination pathway, here we show that two Legionella effectors, named DupA ( d e u biquitinase for P R-ubiquitination) and DupB, reverse PR-ubiquitination by specific removal of phosphoribosyl-Ub (PR-Ub) from substrates. Both DupA and DupB are fully capable of rescuing the Golgi fragmentation phenotype caused by exogenous expression of SdeA in mammalian cells. We further show that deletion of these two genes results in significant accumulation of PR-ubiquitinated species in host cells infected with Legionella . In addition, we have identified a list of specific PR-ubiquitinated host targets and show that DupA and DupB play a role in modulating the association of PR-ubiquitinated host targets with Legionella containing vacuoles (LCV). Together, our data establish a complete PR-ubiquitination and deubiquitination cycle and demonstrate the intricate control that Legionella has over this unusual Ub-dependent posttranslational modification. Statement of significance: Ubiquitination is a vital posttranslational modification in eukaryotes. A variety of microbial pathogens exploit this pathway during their infection. Legionella pneumophila , the causative bacterial pathogen of Legionnaires’ disease, has been show to hijack host ubiquitination pathway via a large number of effectors. Recent studies revealed a family of effectors catalyzing a novel type of Ub-dependent posttranslational modification, namely PR-ubiquitination. Here we report two new players, DupA and DupB, involved in this unconventional pathway. We found that DupA and DupB function as PR-Ub specific DUBs and play a role in regulating the PR-ubiquitination levels of host targets. Our results not only provide an expanding view of the PR-ubiquitination pathway, but may also facilitate the future identification of PR-ubiquitination pathways in eukaryotes.


  • Open Access

    Spatiotemporal Regulation of a Legionella pneumophila T4SS Substrate by the Metaeffector SidJ

    by Kwang Cheol Jeong, Jessica A. Sexton, Joseph P. Vogel

    Modulation of host cell function is vital for intracellular pathogens to survive and replicate within host cells. Most commonly, these pathogens utilize specialized secretion systems to inject substrates (also called effector proteins) that function as toxins within host cells. Since it would be detrimental for an intracellular pathogen to immediately kill its host cell, it is essential that secreted toxins be inactivated or degraded after they have served their purpose. The pathogen Legionella pneumophila represents an ideal system to study interactions between toxins as it survives within host cells for approximately a day and its Dot/Icm type IVB secretion system (T4SS) injects a vast number of toxins. Previously we reported that the Dot/Icm substrates SidE, SdeA, SdeB, and SdeC (known as the SidE family of effectors) are secreted into host cells, where they localize to the cytoplasmic face of the Legionella containing vacuole (LCV) in the early stages of infection. SidJ, another effector that is unrelated to the SidE family, is also encoded in the sdeC-sdeA locus. Interestingly, while over-expression of SidE family proteins in a wild type Legionella strain has no effect, we found that their over-expression in a ∆sidJ mutant completely inhibits intracellular growth of the strain. In addition, we found expression of SidE proteins is toxic in both yeast and mammalian HEK293 cells, but this toxicity can be suppressed by co-expression of SidJ, suggesting that SidJ may modulate the function of SidE family proteins. Finally, we were able to demonstrate both in vivo and in vitro that SidJ acts on SidE proteins to mediate their disappearance from the LCV, thereby preventing lethal intoxication of host cells. Based on these findings, we propose that SidJ acts as a metaeffector to control the activity of other Legionella effectors. A key attribute of many pathogens is their ability to survive and replicate within eukaryotic host cells. One such pathogen, Legionella pneumophila, is able to grow within macrophages in the lungs, thereby causing a form of pneumonia called Legionnaires’ Disease. L. pneumophila causes disease by translocating several hundred proteins into the host cell. These proteins are typically referred to as ‘‘effectors’’, as they function as toxins to alter normal host cell function. However, since L. pneumophila remains within the host cells for approximately one day, continual poisoning of the eukaryotic cells by the bacterial effectors will result in the premature death of the host cell, thus restricting the growth of the pathogen. Previously the L. pneumophila secreted protein LubX was described as a “metaeffector”, which has been defined as an effector that acts directly on another effector to modulate its function inside the host cell. LubX accomplishes this task by directing the degradation of another effector, SidH. Here we report a second L. pneumophila metaeffector, SidJ, acts in a similar manner to neutralize SidE family effectors by removing them from the intracellular compartment that contains the bacterium. This further establishes the concept of metaeffectors, which are likely to be critical to how Legionella and many other pathogens cause disease.


  • Subcellular Localization of the Dot/Icm Type IV Secretion Proteins

    by Kwang Cheol Jeong, Carr D. Vincent, Emily Buford, Joseph P. Vogel

  • The Legionella pneumophila Dot/Icm Type IV Secretion System

    by Carr D. Vincent, Kwang Cheol Jeong, Jessica Sexton, Emily Buford, Joseph P. Vogel

  • Open Access

    Reassessing the Role of DotF in the Legionella pneumophila Type IV Secretion System

    by Molly C. Sutherland, Kelsey A. Binder, Phillip Y. Cualing, Joseph P. Vogel

    Legionella pneumophila, the causative agent of a severe pneumonia termed Legionnaires’ Disease, survives and replicates within both protozoan hosts and human alveolar macrophages. Intracellular survival is dependent upon secretion of a plethora of protein effectors that function to form a replicative vacuole, evade the endocytic pathway and subvert host immune defenses. Export of these factors requires a type IV secretion system (T4SS) called Dot/Icm that is composed of twenty-seven proteins. This report focuses on the DotF protein, which was previously postulated to have several different functions, one of which centered on binding Dot/Icm substrates. In this report, we examined if DotF functions as the T4SS inner membrane receptor for Dot/Icm substrates. Although we were able to recapitulate the previously published bacterial two-hybrid interaction between DotF and several substrates, the interaction was not dependent on the Dot/Icm substrates’ signal sequences as predicted for a substrate:receptor interaction. In addition, binding did not require the cytoplasmic domain of DotF, which was anticipated to be involved in recognizing substrates in the cytoplasm. Finally, inactivation of dotF did not abolish intracellular growth of L. pneumophila or translocation of substrates, two phenotypes dependent on the T4SS receptor. These data strongly suggest that DotF does not act as the major receptor for Dot/Icm substrates and therefore likely performs an accessory function within the core-transmembrane subcomplex of the L. pneumophila Dot/Icm type IV secretion system.


  • Open Access

    The Legionella IcmSW Complex Directly Interacts with DotL to Mediate Translocation of Adaptor-Dependent Substrates

    by Molly C. Sutherland, Thuy Linh Nguyen, Victor Tseng, Joseph P. Vogel

    Legionella pneumophila is a Gram-negative bacterium that replicates within human alveolar macrophages by evasion of the host endocytic pathway through the formation of a replicative vacuole. Generation of this vacuole is dependent upon the secretion of over 275 effector proteins into the host cell via the Dot/Icm type IVB secretion system (T4SS). The type IV coupling protein (T4CP) subcomplex, consisting of DotL, DotM, DotN, IcmS and IcmW, was recently defined. DotL is proposed to be the T4CP of the L. pneumophila T4SS based on its homology to known T4CPs, which function as inner-membrane receptors for substrates. As a result, DotL is hypothesized to play an integral role(s) in the L. pneumophila T4SS for the engagement and translocation of substrates. To elucidate this role, a genetic approach was taken to screen for dotL mutants that were unable to survive inside host cells. One mutant, dotLY725Stop, did not interact with the type IV adaptor proteins IcmS/IcmW (IcmSW) leading to the identification of an IcmSW-binding domain on DotL. Interestingly, the dotLY725Stop mutant was competent for export of one class of secreted effectors, the IcmSW-independent substrates, but exhibited a specific defect in secretion of IcmSW-dependent substrates. This differential secretion illustrates that DotL requires a direct interaction with the type IV adaptor proteins for the secretion of a major class of substrates. Thus, by identifying a new target for IcmSW, we have discovered that the type IV adaptors perform an additional role in the export of substrates by the L. pneumophila Dot/Icm T4SS. Many pathogens are able to survive and grow within eukaryotic host cells. One such pathogen, Legionella pneumophila, is able to replicate within macrophages, resulting in a form of pneumonia called Legionnaires' Disease. One key to L. pneumophila's capacity to cause disease is its ability to translocate several hundred proteins into the host cell. These proteins, typically referred to as “effectors”, function to alter the host cell to create a hospitable environment for the bacteria. L. pneumophila effectors are exported by a specialized export apparatus, which is encoded by the dot/icm genes. However, the mechanism of secretion for these substrates is poorly understood. It is known that a subset of these effectors requires assistance from the type IV adaptor proteins IcmS and IcmW for transport out of the bacterium. It has been shown that IcmSW binds adaptor-dependent secreted proteins in the bacterial cytoplasm prior to their export. Here we report that DotL, an inner membrane component of the Dot/Icm secretion system, also binds IcmSW and this interaction is required for the export of adaptor-dependent substrates. This defines a new role for the type IV adaptors IcmSW and furthers our understanding of how Legionella exports substrates into its host cell.


  • Open Access

    Reclamation of Ampicillin Sensitivity for the Genetic Manipulation of Legionella pneumophila

    by Molly C. Sutherland, Joseph P. Vogel

    Research on Legionella pneumophila , the causative agent of Legionnaires' disease, has been hampered due to the lack of selectable markers for genetic manipulation. We report the construction of a mutant strain of L. pneumophila lacking loxA , a chromosomally encoded β-lactamase, that has enhanced sensitivity to ampicillin. Also described are a method for converting Legionella strains to ampicillin sensitivity and conditions for utilizing bla as a selectable marker.


  • Open Access

    Identification of the DotL coupling protein subcomplex of the Legionella Dot/Icm type IV secretion system

    by Carr D. Vincent, Jonathan R. Friedman, Kwang Cheol Jeong, Molly C. Sutherland, Joseph P. Vogel

    Summary: Legionella pneumophila, the causative agent of Legionnaires' disease, survives in macrophages by altering the endocytic pathway of its host cell. To accomplish this, the bacterium utilizes a type IVB secretion system to deliver effector molecules into the host cell cytoplasm. In a previous report, we performed an extensive characterization of the L. pneumophila type IVB secretion system that resulted in the identification of a critical five‐protein subcomplex that forms the core of the secretion apparatus. Here we describe a second Dot/Icm protein subassembly composed of the type IV coupling protein DotL, the apparatus proteins DotM and DotN, and the secretion adaptor proteins IcmS and IcmW. In the absence of IcmS or IcmW, DotL becomes destabilized at the transition from the exponential to stationary phases of growth, concurrent with the expression of many secreted substrates. Loss of DotL is dependent on ClpA, a regulator of the cytoplasmic protease ClpP. The resulting decreased levels of DotL in the icmS and icmW mutants exacerbates the intracellular defects of these strains and can be partially suppressed by overproduction of DotL. Thus, in addition to their role as chaperones for Legionella type IV secretion system substrates, IcmS and IcmW perform a second function as part of the Dot/Icm type IV coupling protein subcomplex.


  • Identification of Non-dot/icmSuppressors of theLegionella pneumophilaΔdotLLethality Phenotype

    by Carr D. Vincent, Benjamin A. Buscher, Jonathan R. Friedman, Lee Anne Williams, Patrick Bardill, Joseph P. Vogel

    Legionella pneumophila, a causative agent of bacterial pneumonia, survives inside phagocytic cells by avoiding rapid targeting to the lysosome. This bacterium utilizes a type IVB secretion system, encoded by thedot/icmgenes, to replicate inside host cells. DotL, a critical component of the Dot/Icm secretion apparatus, functions as the type IV coupling protein. In contrast to mostdot/icmgenes, which are dispensable for growth on bacteriological media,dotLis required for the viability of wild-typeL. pneumophila. Previously we reported that ΔdotLlethality could be suppressed by inactivation of the Dot/Icm complex via mutations in otherdot/icmgenes. Here we report the isolation of non-dot/icmsuppressors of this phenotype. These ΔdotLsuppressors include insertions that disrupt the function of theL. pneumophilahomologs ofcpxR,djlA,lysS, and two novel open reading frames, lpg0742 and lpg1594, that we have namedldsAandldsBforlethality of ΔdotL suppressor. In addition to suppressing ΔdotLlethality, inactivation of these genes in a wild-type strain background causes a range of defects inL. pneumophilavirulence traits, including intracellular growth, implicating these factors in the proper function of the Dot/Icm complex. Consistent with previous data showing a role for thecpxsystem in regulating expression of severaldot/icmgenes, thecpxRinsertion mutant produced decreased levels of three Dot/Icm proteins, DotA, IcmV, and IcmW. The remaining four suppressors did not affect the steady-state levels of any Dot/Icm protein and are likely to represent the first identified factors necessary for assembly and/or activation of the Dot/Icm secretion complex.